Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Accenture
Chubb
Cantor Fitzgerald
Colorcon
Novartis
Fish and Richardson
Chinese Patent Office
AstraZeneca

Generated: January 18, 2018

DrugPatentWatch Database Preview

Tocainide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tocainide hydrochloride and what is the scope of tocainide hydrochloride patent protection?

Tocainide hydrochloride
is the generic ingredient in one branded drug marketed by Astrazeneca and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tocainide hydrochloride.
Medical Subject Heading (MeSH) Categories for tocainide hydrochloride

US Patents and Regulatory Information for tocainide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for tocainide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Subscribe ➤ Subscribe
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Subscribe ➤ Subscribe
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Subscribe ➤ Subscribe
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
UBS
Teva
Farmers Insurance
Moodys
Harvard Business School
Cantor Fitzgerald
Argus Health
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot